Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.80 -3.13%
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.71, $0.22 better than the analyst estimate of $0.49. Revenue for the quarter came in at $222.2 million versus the consensus estimate of $279 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Trump announces security deal with Denmark on Greenland
- Teva shares Phase 3 data on once-monthly schizophrenia injection
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
